India, along with other WHO-SEAR countries, in September 2013, resolved to eliminate measles and control rubella/congenital rubella syndrome (CRS) by 2020.
Accordingly, Ministry of Health & Family Welfare is introducing Rubella vaccine in its Universal Immunization Programme (UIP) as Measles-Rubella (MR) vaccine.
The vaccine will be introduced as MR Campaign, targeting children from 9 months up to 15 years, in a phased manner over 2 to 3 years, followed by inclusion of the vaccine in routine immunization.
The campaign targets a large birth cohort of approximately 41 crore children, starting in the 1st quarter of 2017. The campaign will be conducted over a period of 3-4 weeks, where vaccination will first be conducted in schools and later in community through outreach.
The campaign aims to rapidly build up immunity against measles and rubella, and also provides a second opportunity for vaccination against measles for children left out in routine immunization.
· Sensitize patients and their relatives.
· Use IMA PvPI number – 9717776514 – to report adverse events.
You can make your clinic a part of the vaccination center.